These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21404072)

  • 21. Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion.
    He X; Hesse LM; Hazarika S; Masse G; Harmatz JS; Greenblatt DJ; Court MH
    Br J Clin Pharmacol; 2009 Nov; 68(5):721-30. PubMed ID: 19916996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bisphenol-A glucuronidation in human liver and breast: identification of UDP-glucuronosyltransferases (UGTs) and influence of genetic polymorphisms.
    Street CM; Zhu Z; Finel M; Court MH
    Xenobiotica; 2017 Jan; 47(1):1-10. PubMed ID: 26999266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional characterization of human cytochrome P4502E1 allelic variants: in vitro metabolism of benzene and toluene by recombinant enzymes expressed in yeast cells.
    Hanioka N; Yamamoto M; Tanaka-Kagawa T; Jinno H; Narimatsu S
    Arch Toxicol; 2010 May; 84(5):363-71. PubMed ID: 20033806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4.
    Aprile S; Del Grosso E; Grosa G
    Drug Metab Dispos; 2010 Jul; 38(7):1141-6. PubMed ID: 20375181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
    Wen Z; Tallman MN; Ali SY; Smith PC
    Drug Metab Dispos; 2007 Mar; 35(3):371-80. PubMed ID: 17151191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender difference in serum bisphenol A levels may be caused by liver UDP-glucuronosyltransferase activity in rats.
    Takeuchi T; Tsutsumi O; Nakamura N; Ikezuki Y; Takai Y; Yano T; Taketani Y
    Biochem Biophys Res Commun; 2004 Dec; 325(2):549-54. PubMed ID: 15530427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights for the risk of bisphenol A: inhibition of UDP-glucuronosyltransferases (UGTs).
    Jiang HM; Fang ZZ; Cao YF; Hu CM; Sun XY; Hong M; Yang L; Ge GB; Liu Y; Zhang YY; Dong Q; Liu RJ
    Chemosphere; 2013 Oct; 93(6):1189-93. PubMed ID: 23948605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and validation of the microRNA response elements in the 3'-untranslated region of the UDP glucuronosyltransferase (UGT) 2B7 and 2B15 genes by a functional genomics approach.
    Papageorgiou I; Court MH
    Biochem Pharmacol; 2017 Dec; 146():199-213. PubMed ID: 28962835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional characterization of cynomolgus monkey UDP-glucuronosyltransferase 1A9.
    Yamamoto K; Mukai M; Nagaoka K; Hayashi K; Hichiya H; Okada K; Murata M; Shigeyama M; Narimatsu S; Hanioka N
    Eur J Drug Metab Pharmacokinet; 2014 Sep; 39(3):195-202. PubMed ID: 24470170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes.
    Kaivosaari S; Toivonen P; Aitio O; Sipilä J; Koskinen M; Salonen JS; Finel M
    Drug Metab Dispos; 2008 Aug; 36(8):1529-37. PubMed ID: 18474681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4-Hydroxy-3-methoxymethamphetamine glucuronide as a phase II metabolite of 3,4-methylenedioxymethamphetamine: enzyme-assisted synthesis and involvement of human hepatic uridine 5'-diphosphate-glucuronosyltransferase 2B15 in the glucuronidation.
    Shoda T; Fukuhara K; Goda Y; Okuda H
    Chem Pharm Bull (Tokyo); 2009 May; 57(5):472-5. PubMed ID: 19420777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation.
    Uchaipichat V; Raungrut P; Chau N; Janchawee B; Evans AM; Miners JO
    Drug Metab Dispos; 2011 Aug; 39(8):1324-8. PubMed ID: 21551257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UDP-glucuronosyltransferase 2B15 (UGT2B15) is the major enzyme responsible for sipoglitazar glucuronidation in humans: retrospective identification of the UGT isoform by in vitro analysis and the effect of UGT2B15*2 mutation.
    Nishihara M; Hiura Y; Kawaguchi N; Takahashi J; Asahi S
    Drug Metab Pharmacokinet; 2013; 28(6):475-84. PubMed ID: 23648677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables.
    Navarro SL; Chen Y; Li L; Li SS; Chang JL; Schwarz Y; King IB; Potter JD; Bigler J; Lampe JW
    Drug Metab Dispos; 2011 Sep; 39(9):1650-7. PubMed ID: 21666065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carboxyl-glucuronidation of mitiglinide by human UDP-glucuronosyltransferases.
    Yu L; Lu S; Lin Y; Zeng S
    Biochem Pharmacol; 2007 Jun; 73(11):1842-51. PubMed ID: 17359941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway.
    Kerdpin O; Knights KM; Elliot DJ; Miners JO
    Biochem Pharmacol; 2008 Jul; 76(2):249-57. PubMed ID: 18541222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes.
    Kilford PJ; Stringer R; Sohal B; Houston JB; Galetin A
    Drug Metab Dispos; 2009 Jan; 37(1):82-9. PubMed ID: 18832476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene.
    Lévesque E; Beaulieu M; Green MD; Tephly TR; Bélanger A; Hum DW
    Pharmacogenetics; 1997 Aug; 7(4):317-25. PubMed ID: 9295060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
    Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
    Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.